- Home
- BLDEW vs SSBK Comparison
BLDEW vs SSBK Comparison
Compare BLDEW & SSBK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BLDEW
- SSBK
- Stock Information
- Founded
- BLDEW 2014
- SSBK 2007
- Country
- BLDEW United States
- SSBK United States
- Employees
- BLDEW 322
- SSBK N/A
- Industry
- BLDEW Transportation Services
- SSBK Commercial Banks
- Sector
- BLDEW Consumer Discretionary
- SSBK Finance
- Exchange
- BLDEW Nasdaq
- SSBK Nasdaq
- Market Cap
- BLDEW N/A
- SSBK N/A
- IPO Year
- BLDEW N/A
- SSBK 2021
- Fundamental
- Price
- BLDEW $0.24
- SSBK $36.37
- Analyst Decision
- BLDEW
- SSBK Buy
- Analyst Count
- BLDEW 0
- SSBK 1
- Target Price
- BLDEW N/A
- SSBK $36.00
- AVG Volume (30 Days)
- BLDEW 51.0K
- SSBK 34.0K
- Earning Date
- BLDEW 03-13-2025
- SSBK 07-21-2025
- Dividend Yield
- BLDEW N/A
- SSBK 0.99%
- EPS Growth
- BLDEW N/A
- SSBK 6.02
- EPS
- BLDEW N/A
- SSBK 3.80
- Revenue
- BLDEW $241,814,000.00
- SSBK $99,026,000.00
- Revenue This Year
- BLDEW N/A
- SSBK $19.18
- Revenue Next Year
- BLDEW N/A
- SSBK $7.05
- P/E Ratio
- BLDEW N/A
- SSBK $9.57
- Revenue Growth
- BLDEW 12.04
- SSBK 18.43
- 52 Week Low
- BLDEW $0.30
- SSBK $25.92
- 52 Week High
- BLDEW $0.36
- SSBK $39.16
- Technical
- Relative Strength Index (RSI)
- BLDEW N/A
- SSBK 61.75
- Support Level
- BLDEW N/A
- SSBK $35.46
- Resistance Level
- BLDEW N/A
- SSBK $36.80
- Average True Range (ATR)
- BLDEW 0.00
- SSBK 0.58
- MACD
- BLDEW 0.00
- SSBK 0.16
- Stochastic Oscillator
- BLDEW 0.00
- SSBK 85.17
About BLDEW Blade Air Mobility Inc.
Blade Air Mobility Inc is a technology-powered air mobility platform that provides air transportation and logistics for hospitals and is a transporter of human organs for transplant, and for passengers, with helicopter and fixed-wing services predominantly in the Northeast United States, Southern Europe and Western Canada. The company's operating segments are; Passenger, and Medical. Majority of the revenue for the company is generated from its Medical segment which predominantly consists of transportation of human organs for transplant and the medical teams supporting these services. It also offers additional services including donor logistics coordination and support in evaluating potential donor organs. A substantial portion of the company's revenue is generated from the United States.